ESR1 (estrogen receptor 1)

2003-02-01  

Identity

HGNC
LOCATION
6q25.1
LOCUSID
ALIAS
ER,ESR,ESRA,ESTRR,Era,NR3A1
FUSION GENES

Other Information

Locus ID:

NCBI: 2099
MIM: 133430
HGNC: 3467
Ensembl: ENSG00000091831

Variants:

dbSNP: 2099
ClinVar: 2099
TCGA: ENSG00000091831
COSMIC: ESR1

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000091831ENST00000206249P03372
ENSG00000091831ENST00000206249G4XH65
ENSG00000091831ENST00000338799P03372
ENSG00000091831ENST00000338799G4XH65
ENSG00000091831ENST00000404742Q5T5H8
ENSG00000091831ENST00000406599Q9H2M1
ENSG00000091831ENST00000415488B0QYW7
ENSG00000091831ENST00000427531H0Y4W6
ENSG00000091831ENST00000440973P03372
ENSG00000091831ENST00000440973G4XH65
ENSG00000091831ENST00000443427P03372
ENSG00000091831ENST00000443427G4XH65
ENSG00000091831ENST00000446550Q9UE35
ENSG00000091831ENST00000456483Q9H2M2
ENSG00000091831ENST00000638569A0A1W2PP92

Expression (GTEx)

0
10
20
30
40
50
60
70
80
90

Pathways

PathwaySourceExternal ID
Endocrine and other factor-regulated calcium reabsorptionKEGGko04961
Endocrine and other factor-regulated calcium reabsorptionKEGGhsa04961
Proteoglycans in cancerKEGGhsa05205
Proteoglycans in cancerKEGGko05205
Estrogen signaling pathwayKEGGhsa04915
Estrogen signaling pathwayKEGGko04915
Prolactin signaling pathwayKEGGhsa04917
Prolactin signaling pathwayKEGGko04917
Thyroid hormone signaling pathwayKEGGhsa04919
Metabolism of proteinsREACTOMER-HSA-392499
Post-translational protein modificationREACTOMER-HSA-597592
Signal TransductionREACTOMER-HSA-162582
Signaling by ERBB4REACTOMER-HSA-1236394
Nuclear signaling by ERBB4REACTOMER-HSA-1251985
Gene ExpressionREACTOMER-HSA-74160
Generic Transcription PathwayREACTOMER-HSA-212436
Nuclear Receptor transcription pathwayREACTOMER-HSA-383280
Endocrine resistanceKEGGko01522
Endocrine resistanceKEGGhsa01522
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factorsREACTOMER-HSA-8864260
TFAP2 (AP-2) family regulates transcription of growth factors and their receptorsREACTOMER-HSA-8866910
DeubiquitinationREACTOMER-HSA-5688426
Ovarian tumor domain proteasesREACTOMER-HSA-5689896
Breast cancerKEGGko05224
Breast cancerKEGGhsa05224

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA152241907lapatinibChemicalLabelAnnotationassociated
PA164712331Alkylating AgentsChemicalClinicalAnnotationassociatedPD21430602
PA164746311everolimusChemicalLabelAnnotationassociated
PA164747170fulvestrantChemicalLabelAnnotation, Literature, MultilinkAnnotationassociated24185510, 24185512
PA164747674goserelinChemicalLabelAnnotationassociated
PA164754789conjugated estrogensChemicalClinicalAnnotationassociatedPD9860300
PA164920420olaparibChemicalLabelAnnotationassociated
PA165110439ixabepiloneChemicalLabelAnnotationassociated
PA165290933pertuzumabChemicalLabelAnnotationassociated
PA165291472neratinibChemicalLabelAnnotationassociated
PA166048848MenopauseDiseaseClinicalAnnotationassociatedPD27546373
PA166153469palbociclibChemicalLabelAnnotationassociated
PA166153470ribociclibChemicalLabelAnnotationassociated
PA166153471abemaciclibChemicalLabelAnnotationassociated
PA166182723eribulinChemicalLabelAnnotationassociated
PA166184523alpelisibChemicalLabelAnnotationassociated
PA361UGT2B7GeneLiterature, MultilinkAnnotationassociated24879639
PA37186UGT2B10GeneLiterature, MultilinkAnnotationassociated24879639
PA37188UGT2B15GeneLiterature, MultilinkAnnotationassociated24879639
PA443434Arthritis, RheumatoidDiseaseClinicalAnnotationassociatedPD21174621
PA443560Breast NeoplasmsDiseaseClinicalAnnotationassociatedPD26536870
PA445062NeoplasmsDiseaseClinicalAnnotationassociatedPD21430602
PA447215Psychotic DisordersDiseaseClinicalAnnotationassociatedPD19386276
PA447216SchizophreniaDiseaseClinicalAnnotationassociatedPD27546373
PA448432anastrozoleChemicalClinicalAnnotation, LabelAnnotationassociatedPD
PA449014cisplatinChemicalClinicalAnnotationassociatedPD21430602
PA449383docetaxelChemicalLabelAnnotationassociated
PA449415doxycyclineChemicalLiterature, MultilinkAnnotationassociated24185512
PA449563exemestaneChemicalClinicalAnnotation, LabelAnnotationassociatedPD26536870
PA450192leflunomideChemicalClinicalAnnotationassociatedPD21174621
PA450196letrozoleChemicalClinicalAnnotation, LabelAnnotationassociatedPD26536870
PA450344medroxyprogesteroneChemicalClinicalAnnotationassociatedPD9860300
PA450403methamphetamineChemicalClinicalAnnotationassociatedPD19386276
PA451221raloxifeneChemicalClinicalAnnotation, LabelAnnotationassociatedPD27546373
PA451581tamoxifenChemicalClinicalAnnotation, LabelAnnotation, Literature, MultilinkAnnotationassociatedPD17713466, 24185510, 24185512
PA451731toremifeneChemicalLabelAnnotationassociated
PA451743trastuzumabChemicalLabelAnnotationassociated

References

Pubmed IDYearTitleCitations
198903232009An oestrogen-receptor-alpha-bound human chromatin interactome.665
160091312005Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1.610
171927852007Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.609
194360382009Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.573
146755392003Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter.561
241855102013Activating ESR1 mutations in hormone-resistant metastatic breast cancer.332
241855122013ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.326
192190422009Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1.273
126674522003Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling.260
195744862009Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival.250

Citation

Dessen P

ESR1 (estrogen receptor 1)

Atlas Genet Cytogenet Oncol Haematol. 2003-02-01

Online version: http://atlasgeneticsoncology.org/gene/40499/esr1-(estrogen-receptor-1)